azelastine nasal
Selected indexed studies
- Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial. (JAMA Intern Med, 2025) [PMID:40892398]
- Allergic Rhinitis: A Review. (JAMA, 2024) [PMID:38470381]
- Azelastine Nasal Spray in Non-Hospitalized Subjects with Mild COVID-19 Infection: A Randomized Placebo-Controlled, Parallel-Group, Multicentric, Phase II Clinical Trial. (Viruses, 2024) [PMID:39772221]
_Worker-drafted node — pending editorial review._
Connections
azelastine nasal is a side effect of
Sources
- Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial. (2025) pubmed
- Allergic Rhinitis: A Review. (2024) pubmed
- Azelastine Nasal Spray in Non-Hospitalized Subjects with Mild COVID-19 Infection: A Randomized Placebo-Controlled, Parallel-Group, Multicentric, Phase II Clinical Trial. (2024) pubmed
- Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients. (2023) pubmed
- Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis. (2003) pubmed
- Azelastine. (2006) pubmed
- Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysis. (2024) pubmed
- Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis. (1999) pubmed
- Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis. (2007) pubmed
- Azelastine nasal spray inhibiting sympathetic function on human nasal mucosa in patients with allergy rhinitis. (2019) pubmed